Proposome for transdermal delivery of tofacitinib

[Display omitted] Tofacitinib citrate (TC) has recently gained interest in treating skin disorders such as psoriasis, atopic dermatitis and baldness. Unfortunately, the oral administration shows side effects, such as decreased neutrophil counts. To this end, the topical delivery of TC can be used to...

Full description

Saved in:
Bibliographic Details
Published inInternational journal of pharmaceutics Vol. 585; p. 119558
Main Authors Kathuria, Himanshu, Nguyen, Diep T.P., Handral, Harish K., Cai, Junyu, Cao, Tong, Kang, Lifeng
Format Journal Article
LanguageEnglish
Published Netherlands Elsevier B.V 30.07.2020
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:[Display omitted] Tofacitinib citrate (TC) has recently gained interest in treating skin disorders such as psoriasis, atopic dermatitis and baldness. Unfortunately, the oral administration shows side effects, such as decreased neutrophil counts. To this end, the topical delivery of TC can be used to reduce the risk associated with systemic exposure. However, TC shows minimal absorption via skin. Hence, the objective of this study is to enhance the skin delivery of TC using a non-invasive approach. The liposomes based on propylene glycol, named as proposomes, carrying TC, were studied. The vesicle characteristics and in vitro skin permeation were assessed. The proposomes enhanced the skin permeability of TC by 4–11 folds. The composition of proposomes was found to affect the skin permeation and deposition of TC. The proposomes were stable for at least 6 months. Overall, proposomes were effective for targeted topical drug delivery.
ISSN:0378-5173
1873-3476
DOI:10.1016/j.ijpharm.2020.119558